These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21695058)

  • 1. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression.
    Murakami M; Giampietro C; Giannotta M; Corada M; Torselli I; Orsenigo F; Cocito A; d'Ario G; Mazzarol G; Confalonieri S; Di Fiore PP; Dejana E
    PLoS One; 2011; 6(6):e21242. PubMed ID: 21695058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of junctional adhesion molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration.
    Murakami M; Francavilla C; Torselli I; Corada M; Maddaluno L; Sica A; Matteoli G; Iliev ID; Mantovani A; Rescigno M; Cavallaro U; Dejana E
    Cancer Res; 2010 Mar; 70(5):1759-65. PubMed ID: 20160037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment.
    Bednarek R; Selmi A; Wojkowska D; Karolczak K; Popielarski M; Stasiak M; Salifu MO; Babinska A; Swiatkowska M
    Breast Cancer Res Treat; 2020 Jan; 179(2):325-335. PubMed ID: 31650345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
    Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
    Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
    Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion.
    Naik MU; Naik TU; Suckow AT; Duncan MK; Naik UP
    Cancer Res; 2008 Apr; 68(7):2194-203. PubMed ID: 18381425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilayered proteomics reveals that JAM-A promotes breast cancer progression via regulation of amino acid transporter LAT1.
    Magara K; Takasawa A; Takasawa K; Aoyama T; Ota M; Kyuno D; Ono Y; Murakami T; Yamamoto S; Nakamori Y; Nakahashi N; Kutomi G; Takemasa I; Hasegawa T; Osanai M
    Cancer Sci; 2024 Sep; 115(9):3153-3168. PubMed ID: 38943512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
    Kakogiannos N; Ferrari L; Giampietro C; Scalise AA; Maderna C; Ravà M; Taddei A; Lampugnani MG; Pisati F; Malinverno M; Martini E; Costa I; Lupia M; Cavallaro U; Beznoussenko GV; Mironov AA; Fernandes B; Rudini N; Dejana E; Giannotta M
    Circ Res; 2020 Sep; 127(8):1056-1073. PubMed ID: 32673519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression.
    Zhang M; Luo W; Huang B; Liu Z; Sun L; Zhang Q; Qiu X; Xu K; Wang E
    PLoS One; 2013; 8(11):e79173. PubMed ID: 24265754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer.
    Lampis A; Hahne JC; Gasparini P; Cascione L; Hedayat S; Vlachogiannis G; Murgia C; Fontana E; Edwards J; Horgan PG; Terracciano L; Sansom OJ; Martins CD; Kramer-Marek G; Croce CM; Braconi C; Fassan M; Valeri N
    Cell Death Differ; 2021 Oct; 28(10):2970-2982. PubMed ID: 34226680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings.
    Leech AO; Vellanki SH; Rutherford EJ; Keogh A; Jahns H; Hudson L; O'Donovan N; Sabri S; Abdulkarim B; Sheehan KM; Kay EW; Young LS; Hill ADK; Smith YE; Hopkins AM
    Breast Cancer Res; 2018 Nov; 20(1):140. PubMed ID: 30458861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
    Wang Y; Lui WY
    Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
    Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
    Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration.
    Khandoga A; Kessler JS; Meissner H; Hanschen M; Corada M; Motoike T; Enders G; Dejana E; Krombach F
    Blood; 2005 Jul; 106(2):725-33. PubMed ID: 15827135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.
    Vetrano S; Rescigno M; Cera MR; Correale C; Rumio C; Doni A; Fantini M; Sturm A; Borroni E; Repici A; Locati M; Malesci A; Dejana E; Danese S
    Gastroenterology; 2008 Jul; 135(1):173-84. PubMed ID: 18514073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus.
    Kelly KR; Espitia CM; Zhao W; Wendlandt E; Tricot G; Zhan F; Carew JS; Nawrocki ST
    Oncotarget; 2015 Dec; 6(38):41275-89. PubMed ID: 26513296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Junctional adhesion molecule-A promotes proliferation and inhibits apoptosis of gastric cancer.
    Ikeo K; Oshima T; Shan J; Matsui H; Tomita T; Fukui H; Watari J; Miwa H
    Hepatogastroenterology; 2015; 62(138):540-5. PubMed ID: 25916097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution.
    Schmitt MM; Fraemohs L; Hackeng TM; Weber C; Koenen RR
    Atherosclerosis; 2014 Jun; 234(2):254-64. PubMed ID: 24704627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.
    McSherry EA; Brennan K; Hudson L; Hill AD; Hopkins AM
    Breast Cancer Res; 2011 Mar; 13(2):R31. PubMed ID: 21429211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.